Home/Filings/4/0001415889-21-000735
4//SEC Filing

Belloff Neil S. 4

Accession 0001415889-21-000735

CIK 0001035354other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 6:40 PM ET

Size

5.8 KB

Accession

0001415889-21-000735

Insider Transaction Report

Form 4
Period: 2021-02-12
Belloff Neil S.
General Counsel and Secretary
Transactions
  • Award

    Stock Options

    2021-02-12+120,000120,000 total
    Exercise: $4.04Exp: 2031-02-12Common Stock (120,000 underlying)
Footnotes (2)
  • [F1]The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
  • [F2]The options vest and become exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on February 12, 2022, and the remainder vesting in twelve equal quarterly installments thereafter.

Issuer

Eloxx Pharmaceuticals, Inc.

CIK 0001035354

Entity typeother

Related Parties

1
  • filerCIK 0001741670

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:40 PM ET
Size
5.8 KB